About the GHIT Fund

GHIT Management Team

Senior Management

  • Kei Katsuno, MD, MPH Senior Director, Investment Strategy & Government Relations

    Kei Katsuno is Senior Director of Investment Strategy & Government Relations at the GHIT Fund. Prior to his current assignment, he worked as a Health Specialist at the World Bank, following his completion of a fellowship at the Asia Pacific Leadership Program at the East West Center. Dr. Katsuno graduated from the University of Tokyo with a medical degree and worked as a medical doctor in the Emergency Medicine Department of the National Center for Global Health and Medicine (formerly International Medical Center of Japan). He possesses both Japanese and U.S. medical licenses (ECFMG) and completed the Master of Public Health (MPH) program at the Johns Hopkins University as a Fulbright Scholar. He is a lecturer at the Department of Biomedical Chemistry, Graduate School of Medicine at the University of Tokyo, and a fellow of the U.S.-Japan Leadership Program.
  • Masayuki Sato, MBA Vice President, External Affairs

    Masayuki Sato currently serves as Vice President of External Affairs and brings a wealth of experience from the pharmaceutical sector where he worked previously for companies including Toray, Otsuka and GlaxoSmithKline (GSK) in areas of corporate strategy and planning, sales strategy, business development and external relations. Previously, Mr. Sato was a founding member of two start-up joint ventures for GSK: ViiV Healthcare with Pfizer/Shionogi, and Japan Vaccine with Daiichi-Sankyo. He holds an MBA from Keio University, and a Bachelor of Economics from Hokkaido University in Japan. He is a Chartered Member of the Security Analysts Association of Japan (CMA).
  • Executive Director BT Slingsby, MD, PhD, MPH CEO, Global Health Innovative Technology Fund

    Dr. Slingsby is CEO & Executive Director of the GHIT Fund — the World's first public-private fund focused on the development of new medicines for low- and middle-income countries. Previously, he was the global head for access strategies at Eisai Co., Ltd. where he developed new business models for R&D and overlooked market access in the developing world. Dr. Slingsby has helped launch numerous start-ups in Japan and the U.S., and currently advises at the Graduate School of Medicine at the University of Tokyo and Kyoto University. He is a member of the Public-Private Partnership Forum at the National Academy of Medicine in the U.S. and the Global Health and Human Security Program, and has published over 50 peer-reviewed articles on medicine and public health in both Japanese and, American literature. Dr. Slingsby graduated from Brown University, earned his Masters and Doctorate from Kyoto University, and the University of Tokyo, and received his Medical Doctorate from the George Washington University.
  • Miho Takazawa, MBA Director of Finance

    Miho Takazawa is Director of Finance at the Global Health Innovative Technology Fund. Previously, she was Finance Manager in charge of Corporate/Special Purpose Company (SPC) Accounting and Treasury at Mapletree Investments Japan K.K., a Singaporean Real Estate Investment/Asset Management Company based in Japan. Prior to that she served in the Accounting Department at Fuji Bank/Mizuho Corporate Bank (now Mizuho Bank) in New York City. She holds an MBA and a BS in International Business from Southern New Hampshire University in the United States and a BA in the History of Chinese Thought from Atomi University in Japan.
  • Bumpei Tamamura, MPH Senior Director, Brand Communications

    Bumpei Tamamura is Senior Director of Brand Communications. Before his position at the GHIT Fund, he worked as a strategic planner at communication agency and social marketing venture and was responsible for marketing and communication strategy and execution. He had a wide range of clients from international organization, ministries, universities, research institutions and pharmaceutical companies. Mr. Tamamura graduated from Tokyo University of Pharmacy and Life Sciences, and received his master degree from Boston University School of Public Health.
  • Hayato Urabe, PhD, MPIA Director, Investment Strategy, Planning & Management

    Hayato Urabe is Director of Investment Strategy and Management. He oversees all the portfolio management activities at GHIT. Prior to joining the GHIT Fund, Dr. Urabe held several positions across the energy, life sciences, and water treatment technologies focusing on strategy planning, startup due diligence and project management in the Silicon Valley. He has also held consultant position at Synthetic Genomics for technologies ranging from nutrigenomics to biofuels.

    Dr. Urabe completed his Bachelor of Science in Molecular Biology, Master of Science in Innovation Management and Entrepreneurship Engineering, and Doctor of Philosophy in Biomedical engineering from Brown University. In addition, Dr. Urabe completed Masters program from the School of Global Policy and Strategy at University of California, San Diego.
  • Kio Yamabe, MBA Chief Operating Officer

    Kio Yamabe is Chief Operating Officer at the Global Health Innovative Technology Fund, where he leads operations, human resources, legal and compliance, and also oversees finance and investment. Mr. Yamabe has more than 25 years of management experience in the pharmaceutical and healthcare industry, including as President and Country Manager of Carestream Health and CSL Behring. He has lived and worked in Australia, Switzerland, the United Kingdom, and the United States, including as Head of International Business at First Retailing Co., Ltd., where he led the launch of UNIQLO stores in London. He received his MBA from IMD in Switzerland and a BS from Seinan Gakuin University in Japan.